Malaria
New Editorial in the New England Journal of Medicine Highlights Importance of Integrating Neglected Tropical Disease (NTD) Treatments Into Existing Control Programs for HIV-AIDs, Tuberculosis and Malaria
June 2, 2011
A new perspective authored by Peter Hotez, Jeffrey Sachs and others in the New England Journal of Medicine reinforces the importance of integrating neglected tropical disease (NTD) control measures into existing control efforts for HIV/AIDS, tuberculosis and malaria.
Vaccine Information Session
14 - 15 April 2011
The Sabin Vaccine Institute in partnership with Universidad Peruana Cayetano Heredia convened the Vaccine Information Session in Lima, Peru on April 14 – 15, 2011. The two day meeting was organized for journalists currently reporting on Global Health and attracted 30 journalists from 17 countries in the Region of the Americas.
Malaria Vaccine Program (MVP)
In 2009, Sabin Vaccine Development entered into collaboration with the PATH Malaria Vaccine Initiative (MVI) and Johns Hopkins Bloomberg School of Public Health to study the feasibility of a transmission blocking vaccine for malaria. This vaccine approach aims to stop the malaria parasite from developing in the mosquito, effectively blocking transmission of malaria from mosquitoes to humans.
Print this page
Email this page